Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isodiol International Inc ISOLF

Healthcare Drug Manufacturers - Specialty & Generic Cannabis
Isodiol International Inc is a manufacturer and developer of phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. It generates revenue from the sale of nutritional health products derived from hemp. Geographically, it derives a majority of revenue from the United States and also has a presence in Canada. Its product categories include Tinctures; Capsules; Topicals; Vape; Oral Spray; Skincare; and others.


GREY:ISOLF - Post by User

Isodiol International Inc
Bullboard Posts
User Avatar Image
(10)
•••
Comment by ttboy29on Jul 04, 2018 2:09pm
42 Views
Post# 28268259

RE:RE:RE:RE:ISOL LOVES FRIDAYS! GOOD NEWS COMING

RE:RE:RE:RE:ISOL LOVES FRIDAYS! GOOD NEWS COMING
rvvs7269 wrote: jumping the gun a bit arnt we now? 25 million a quarter

sounds good to me but the big money is in this medical product isol has at 6000mg of cbd strawberry flavor.

patent or licence will send this through the roof

the coffee alone if they can scure a deal with tim hortons will provide that income

the water deal is litteraly printing money 

also they still may get taken out or hostile take over someone has been accumulating for 7 months



He said never. They are doing 10 million a quater now and if they aren't doing 25M a quarter in 2019 year then they are doing something wrong. $25M is nothing. If CBD is not  a controlled substance in the US the demand should be through the roof. 
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities